June, 2018
www.us-tech.com
Page 29 Plasma Treatment Adding Value to Plastic Labware Continued from previous page
can be detected by a secondary anti- body that is linked to an enzyme through bioconjugation. In a final step, the plate is de-
veloped by adding an enzymatic sub- strate to produce a visible signal, which indicates the quantity of anti- gen in the sample.
drophobic coating on the inside and out of the pipette tip. The company has already de-
signed special trays and fixtures ca- pable of treating entire racks for 96 and 384 well microtiter plates. The process utilizes pulses of plasma that activate a specific monomer, causing it to diffuse and polymerize within the pipette tip.
R&D Assistance According to Barden, plasma
treatment is common enough that leading equipment providers are able to modify existing, mature tools and technology, complete with fixturing, to deliver what are essentially drop- in solutions.
Some providers even provide ac-
cess to onsite research and develop- ment equipment, as well as engineer-
Plasma treatment is common enough that leading equip- ment providers are able to
modify existing, mature tools and technology,
complete with fixturing, to
deliver what are essentially drop-in solutions.
ing expertise. PVA TePla, for exam- ple, often invites labware manufac- turers to visit its lab in Corona, Cali- fornia. The purpose of these visits is
to run parts and conduct experi- ments on in-house equipment, with full customer involvement. It is dur- ing these technical customer and supplier meetings that many of the best experimental matrices and ideas are produced. “The elegance of these solutions
is that they leverage existing tech- nology and know-how, as opposed to creating something that is complete- ly new,” says Barden. “Access to this knowledge base facilitates new en- trants into the market.” Contact: PVA TePla America,
Inc., 251 Corporate Terrace, Corona, CA 92879 % 951-371-2500 fax: 951-371-9792 Web:
www.pvateplaamerica.com r
The PVA process uses pulses of plasma that activate a specific monomer, causing it to diffuse and polymerize within pipette tips.
To improve the bond and func-
tion of the antibody, plasma coatings can be applied to orient the Y-shaped IgG proteins utilized in the majority of these types of tests. Failure to do so can mean some antibodies face down or deform and become essentially un- available for bonding with antigens. “With most uncoated polymer
surfaces you can’t control how the Y- shaped ‘capture’ antibodies are orient- ed,” says Barden. “However, a func- tional coating can be used to favor the proper upward orientation so the en- tire surface is available for the assay. In this way, we can improve the sig- nal-to-noise and dynamic range of an assay.” For this, applying an amine coating is a popular solution. “Amine coatings are commonly
used because they have a middle sur- face energy, with water contact an- gles of approximately 60 degrees,” says Barden. “So the coating is hy- drophilic enough that the liquid dis- perses well and hydrophobic enough to facilitate bonding of the material.”
Pipette Tips Pipettes are another common
laboratory tool. Often constructed of high-density polyethylene or polypro - pylene that tends to be hydrophobic, pipettes can still have difficulties with liquids sticking to the surface — par- ticularly on, or around, the tip. To address this issue, some
pipette manufacturers add fluorinat- ed polymers within the polypropy- lene during the injection molding process. However, there can still be issues, such as phase separation or leaching. To ensure pipette tips “sheet” off any aqueous solution more effectively, companies like PVA TePla can utilize nanotechnology to create a superhydrophobic surface. One such technique involves
etching the surface to roughen it such that air, nitrogen, oxygen and other gases are trapped in the recess- es, allowing the liquid to float on the top in a “lotus affect.” Another method involves applying a more hy-
See at SMT/Hybrid Pkg, Booth 4A-458
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104